Physicians and drug representatives: exploring the dynamics of the relationship
about
Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewExposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.The association between money and opinion in academic emergency medicine.Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.Establishing the need and identifying goals for a curriculum in medical business ethics: a survey of students and residents at two medical centers in Missouri.Physicians' perceptions of medical representative visits in Yemen: a qualitative study.Disclosures of funding sources and conflicts of interest in published HIV/AIDS research conducted in developing countries.A systematic review of the relationship between plastic surgery and the medical industryPharmacists' Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-Making."We can't get along without each other": Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety.Changing interactions between physician trainees and the pharmaceutical industry: a national survey.Attitude and practice of dental surgeons towards pharmaceutical companies' marketing giftsProfessionalism perspectives among medical students of a novel medical graduate school in Malaysia.Prescribers and pharmaceutical representatives: why are we still meeting?Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.Ethical issues in new drug prescribing.The Physician Payments Sunshine Act and the unaddressed role of nurses: an interest group analysis.Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act.Types and Distribution of Payments From Industry to Physicians in 2015.Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.The high costs of "free" drug samples.Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.Physicians under the influence: social psychology and industry marketing strategies.Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.[Comments on language of psychiatrists and stigmatization of the mentally ill].Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.Toward evidence-based conflicts of interest training for physician-investigators.Drug detailers, professionalism, and prudence.What do they do? Interactions between village doctors and medical representatives in Chakaria, Bangladesh
P2860
Q28475841-D82EA20E-A1A9-4A39-B8F5-376489532278Q33753326-0D01C254-2959-49DF-83AF-EED67BCCF47AQ34014179-10B37845-B1E0-4559-9AE6-DF91E0D43040Q34215520-1D7DB174-0BED-4935-B3F9-D37AB129225DQ34362925-506C3A1E-3ABB-4E1F-81E6-1870011BCC2CQ34958916-B51C3911-9A57-45F8-BB52-50AF214388B8Q35153733-5C72E17D-3529-4B37-8D22-C1C99E2C3660Q35281894-508ED540-F59B-4137-BB29-434776C51323Q36161200-E38382B6-B9C2-41E5-B3BF-8CBC8ECBAE40Q36328375-224EB5CA-8503-4243-899E-1F0D7A88CC66Q37009211-7F0D7BFF-64D9-490C-BDD7-A681AD5D4EE1Q37086791-B1ED2478-E11A-4963-8138-C3E3DA0921BCQ37138525-4E29575E-3225-4DDD-9B7B-C4482E2B9AF1Q37225206-7CEEAD7B-B36B-42B0-89B4-D28C65212E0FQ38051677-3C106107-6D03-4FA6-A073-7B011714D299Q38062469-F851E3AE-FD82-4BBE-8C10-31B4FDB22552Q38082293-B79ACEFB-4A58-4C52-9960-7C5E0B93024AQ38767427-5DAA6216-E352-4040-A56A-B3856BDB0708Q38808789-4CE7B220-FF93-44D0-8ED3-11E947AB7878Q41677333-EB61E8FD-6E7E-4833-87FD-672AFD89A9F5Q42215595-1350BCA9-8BFD-4A4C-A4ED-97FE7A5409C9Q42726613-E3C467DF-C52A-4800-94CC-9425FFA9C8B1Q43757409-8C8C9825-37B5-4AFC-ABAE-A92D79BB75B7Q43982295-D6C805B7-C964-466B-972B-986FE5C271F0Q44902330-F06F3A07-A623-43B8-89BD-710E6EEF86CDQ46610639-68290758-6602-4F19-A9D5-139688FE9F94Q47657946-6FEF8C2D-730B-4A01-BF75-752EE93894FEQ47950873-2F3963A7-1B64-4EE8-AADD-FE04D9044DFDQ48909275-3E4D35FA-9962-411A-A387-2572D6D00815Q58480164-6C08DFCD-AFC7-4480-9EEC-E0FF62A72BA4
P2860
Physicians and drug representatives: exploring the dynamics of the relationship
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Physicians and drug representatives: exploring the dynamics of the relationship
@ast
Physicians and drug representatives: exploring the dynamics of the relationship
@en
type
label
Physicians and drug representatives: exploring the dynamics of the relationship
@ast
Physicians and drug representatives: exploring the dynamics of the relationship
@en
prefLabel
Physicians and drug representatives: exploring the dynamics of the relationship
@ast
Physicians and drug representatives: exploring the dynamics of the relationship
@en
P2860
P1476
Physicians and drug representatives: exploring the dynamics of the relationship
@en
P2093
David J Rothman
Troyen A Brennan
P2860
P2888
P304
P356
10.1007/S11606-006-0041-Z
P577
2007-02-01T00:00:00Z